Inflexion Outlines Rosemont Investment And Eyes More Generics Deals
June Deal Was Inflexion’s First In Generics Space
In an exclusive interview with Generics Bulletin, Inflexion’s Ben Long reveals his ambitions for newly-acquired UK-based liquids generics specialist Rosemont Pharmaceuticals, including to drive investment in R&D and expand the company’s international footprint.
